Announced
Completed
Financials
Sources
Tags
United Kingdom
medical equipment
medical technology
Friendly
Minority
Acquisition
Cross Border
Completed
Medical Equipment
Private
Private Equity
Venture Capital
Synopsis
Glenview Capital, a capital manager, and Novo Holdings, a life science investor, led a $245m Series D funding round in Quanta Dialysis, a medical technology company. Additional Investors include BlackRock, Eldridge, Sands Capital, Millennium Management, Monashee Investment, Puhua Capital, Segulah Medical, Ancora, Orlando Health, Wellington Partners, btov, Seroba Life Sciences and The Grands. “Quanta’s innovative cartridge-based system is compact, simple, and powerful and provides tremendous value and treatment flexibility for providers and patients across an omni-channel delivery chain, from dedicated dialysis centers, acute care hospitals, and increasingly moving into the home. With this growth capital, Quanta has the resources to drive improved patient outcomes and convenience while accelerating market penetration and scale," Lee Hathaway, Glenview Capital Partner.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.